MCL coexpression mm9:1028: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
|coexpression_dpi_cluster_scores_median=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0354470656487682,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.877753318668592,0.817944053113571,0.633856272871215,0,0,0,0.142658407030909,0,0,0,0,0,0.099424903790252,0.109421078997306,0.180605254120548,0,0,0,0,0,0,0,0,0,0.141204588184303,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.127383644231484,0.100296779313498,0,0,0.358556276484448,0,0.909056572608405,0.0851089148667383,0.245532308442916,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0509235292940968,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0623063220167371,0,0,0.0479619276176895,0,0,0.0338533374824575,0.0592603993571966,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.046982063026719,0,0,0.0769870445726752,0.0294389011296462,0,0,0.0633328814307688,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.136564059910207,0,0,0,0,0,0,0.0774164737207147,0,0,0,0,0.0691813633419548,0,0,0,0,0,0,0,0,0,0,0,0,0.0930603692915911,0,0,0,0,0,0,0.108524491213051,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.083442441818608,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.034489466458534,0,0,0,0,0,0,0,0.0527554171614426,0,0,0,0.0433069931089932,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0767094571656325,0,0.0730404042754446,0.0843504501108034,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0242538736058389,0,0,0,0,0.0596387295197733,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |coexpression_dpi_cluster_scores_median=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0354470656487682,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.877753318668592,0.817944053113571,0.633856272871215,0,0,0,0.142658407030909,0,0,0,0,0,0.099424903790252,0.109421078997306,0.180605254120548,0,0,0,0,0,0,0,0,0,0.141204588184303,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.127383644231484,0.100296779313498,0,0,0.358556276484448,0,0.909056572608405,0.0851089148667383,0.245532308442916,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0509235292940968,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0623063220167371,0,0,0.0479619276176895,0,0,0.0338533374824575,0.0592603993571966,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.046982063026719,0,0,0.0769870445726752,0.0294389011296462,0,0,0.0633328814307688,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.136564059910207,0,0,0,0,0,0,0.0774164737207147,0,0,0,0,0.0691813633419548,0,0,0,0,0,0,0,0,0,0,0,0,0.0930603692915911,0,0,0,0,0,0,0.108524491213051,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.083442441818608,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.034489466458534,0,0,0,0,0,0,0,0.0527554171614426,0,0,0,0.0433069931089932,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0767094571656325,0,0.0730404042754446,0.0843504501108034,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0242538736058389,0,0,0,0,0.0596387295197733,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | ||
|gostat_on_MCL_coexpression=GO:0005176;ErbB-2 class receptor binding;0.0258495539819157;211323!GO:0046579;positive regulation of Ras protein signal transduction;0.0258495539819157;211323!GO:0045213;neurotransmitter receptor metabolic process;0.0258495539819157;211323!GO:0051057;positive regulation of small GTPase mediated signal transduction;0.0258495539819157;211323!GO:0043624;cellular protein complex disassembly;0.0258495539819157;211323!GO:0043241;protein complex disassembly;0.0258495539819157;211323!GO:0032984;macromolecular complex disassembly;0.0258495539819157;211323!GO:0007416;synaptogenesis;0.0269185018583432;211323!GO:0048663;neuron fate commitment;0.0269185018583432;211323!GO:0022411;cellular component disassembly;0.0269185018583432;211323!GO:0007422;peripheral nervous system development;0.0269185018583432;211323!GO:0043112;receptor metabolic process;0.0269185018583432;211323!GO:0010001;glial cell differentiation;0.0377552695103153;211323!GO:0042063;gliogenesis;0.0378231262427327;211323!GO:0050808;synapse organization and biogenesis;0.037881510381851;211323! | |gostat_on_MCL_coexpression=GO:0005176;ErbB-2 class receptor binding;0.0258495539819157;211323!GO:0046579;positive regulation of Ras protein signal transduction;0.0258495539819157;211323!GO:0045213;neurotransmitter receptor metabolic process;0.0258495539819157;211323!GO:0051057;positive regulation of small GTPase mediated signal transduction;0.0258495539819157;211323!GO:0043624;cellular protein complex disassembly;0.0258495539819157;211323!GO:0043241;protein complex disassembly;0.0258495539819157;211323!GO:0032984;macromolecular complex disassembly;0.0258495539819157;211323!GO:0007416;synaptogenesis;0.0269185018583432;211323!GO:0048663;neuron fate commitment;0.0269185018583432;211323!GO:0022411;cellular component disassembly;0.0269185018583432;211323!GO:0007422;peripheral nervous system development;0.0269185018583432;211323!GO:0043112;receptor metabolic process;0.0269185018583432;211323!GO:0010001;glial cell differentiation;0.0377552695103153;211323!GO:0042063;gliogenesis;0.0378231262427327;211323!GO:0050808;synapse organization and biogenesis;0.037881510381851;211323! | ||
|ontology_enrichment_celltype=CL:0000680!6.13e-16!6;CL:0000183!6.13e-16!6;CL:0000187!6.13e-16!6;CL:0000056!6.13e-16!6;CL:0000222!1.52e-13!7;CL:0000355!2.37e-10!9;CL:0000192!4.24e-09!3;CL:0000359!4.24e-09!3;CL:0002539!4.24e-09!3;CL:0000514!4.24e-09!3;CL:0002494!1.81e-08!3;CL:0000737!1.81e-08!3;CL:0000746!1.81e-08!3;CL:0000513!1.81e-08!3 | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_uberon=UBERON:0001134!2.37e-10!9;UBERON:0002036!2.37e-10!9;UBERON:0002385!2.37e-10!9;UBERON:0000486!2.37e-10!9;UBERON:0007503!2.37e-10!9;UBERON:0001015!2.37e-10!9;UBERON:0002329!2.37e-10!9;UBERON:0003082!2.37e-10!9;UBERON:0003059!2.37e-10!9;UBERON:0007282!2.37e-10!9;UBERON:0004290!2.37e-10!9;UBERON:0009618!2.37e-10!9;UBERON:0000383!3.11e-09!10;UBERON:0001135!4.24e-09!3;UBERON:0004237!4.24e-09!3;UBERON:0004695!4.24e-09!3;UBERON:0002111!4.24e-09!3;UBERON:0004178!4.24e-09!3;UBERON:0003103!5.45e-09!43;UBERON:0004535!5.65e-09!23;UBERON:0001009!5.65e-09!23;UBERON:0007524!2.56e-08!11;UBERON:0003077!2.56e-08!11;UBERON:0007285!2.56e-08!11;UBERON:0004872!2.86e-08!33;UBERON:0000947!6.87e-07!4;UBERON:0001637!6.87e-07!4;UBERON:0004573!6.87e-07!4;UBERON:0003509!6.87e-07!4;UBERON:0004571!6.87e-07!4;UBERON:0010191!6.87e-07!4;UBERON:0004572!6.87e-07!4 | |||
}} | }} |
Revision as of 16:12, 11 October 2012
Phase1 CAGE Peaks
Short description | |
---|---|
Mm9::chr10:58071854..58071882,+ | p@chr10:58071854..58071882 + |
Mm9::chr1:127573438..127573451,+ | p5@Gpr39 |
Mm9::chr1:127573708..127573719,+ | p9@Gpr39 |
Mm9::chr1:127573773..127573786,+ | p6@Gpr39 |
Mm9::chr1:137662814..137662817,+ | p5@Phlda3 |
Mm9::chr2:50152414..50152430,+ | p2@ENSMUST00000123699 |
Mm9::chr8:33119942..33119952,- | p4@Nrg1 |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0005176 | ErbB-2 class receptor binding | 0.0258495539819157 |
GO:0046579 | positive regulation of Ras protein signal transduction | 0.0258495539819157 |
GO:0045213 | neurotransmitter receptor metabolic process | 0.0258495539819157 |
GO:0051057 | positive regulation of small GTPase mediated signal transduction | 0.0258495539819157 |
GO:0043624 | cellular protein complex disassembly | 0.0258495539819157 |
GO:0043241 | protein complex disassembly | 0.0258495539819157 |
GO:0032984 | macromolecular complex disassembly | 0.0258495539819157 |
GO:0007416 | synaptogenesis | 0.0269185018583432 |
GO:0048663 | neuron fate commitment | 0.0269185018583432 |
GO:0022411 | cellular component disassembly | 0.0269185018583432 |
GO:0007422 | peripheral nervous system development | 0.0269185018583432 |
GO:0043112 | receptor metabolic process | 0.0269185018583432 |
GO:0010001 | glial cell differentiation | 0.0377552695103153 |
GO:0042063 | gliogenesis | 0.0378231262427327 |
GO:0050808 | synapse organization and biogenesis | 0.037881510381851 |
Relative expression of the co-expression cluster over median <br>Analyst:
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
muscle precursor cell | 6.13e-16 | 6 |
contractile cell | 6.13e-16 | 6 |
muscle cell | 6.13e-16 | 6 |
myoblast | 6.13e-16 | 6 |
mesodermal cell | 1.52e-13 | 7 |
multi-potent skeletal muscle stem cell | 2.37e-10 | 9 |
smooth muscle cell | 4.24e-09 | 3 |
vascular associated smooth muscle cell | 4.24e-09 | 3 |
aortic smooth muscle cell | 4.24e-09 | 3 |
smooth muscle myoblast | 4.24e-09 | 3 |
cardiocyte | 1.81e-08 | 3 |
striated muscle cell | 1.81e-08 | 3 |
cardiac muscle cell | 1.81e-08 | 3 |
cardiac muscle myoblast | 1.81e-08 | 3 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 2.37e-10 | 9 |
striated muscle tissue | 2.37e-10 | 9 |
muscle tissue | 2.37e-10 | 9 |
multilaminar epithelium | 2.37e-10 | 9 |
epithelial vesicle | 2.37e-10 | 9 |
musculature | 2.37e-10 | 9 |
somite | 2.37e-10 | 9 |
myotome | 2.37e-10 | 9 |
presomitic mesoderm | 2.37e-10 | 9 |
presumptive segmental plate | 2.37e-10 | 9 |
dermomyotome | 2.37e-10 | 9 |
trunk paraxial mesoderm | 2.37e-10 | 9 |
musculature of body | 3.11e-09 | 10 |
smooth muscle tissue | 4.24e-09 | 3 |
blood vessel smooth muscle | 4.24e-09 | 3 |
arterial system smooth muscle | 4.24e-09 | 3 |
artery smooth muscle tissue | 4.24e-09 | 3 |
aorta smooth muscle tissue | 4.24e-09 | 3 |
compound organ | 5.45e-09 | 43 |
cardiovascular system | 5.65e-09 | 23 |
circulatory system | 5.65e-09 | 23 |
dense mesenchyme tissue | 2.56e-08 | 11 |
paraxial mesoderm | 2.56e-08 | 11 |
presumptive paraxial mesoderm | 2.56e-08 | 11 |
splanchnic layer of lateral plate mesoderm | 2.86e-08 | 33 |
aorta | 6.87e-07 | 4 |
artery | 6.87e-07 | 4 |
systemic artery | 6.87e-07 | 4 |
arterial blood vessel | 6.87e-07 | 4 |
systemic arterial system | 6.87e-07 | 4 |
aortic system | 6.87e-07 | 4 |
arterial system | 6.87e-07 | 4 |
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |